Four primary biomarkers are analyzed during the routine pathological work-up for breast cancer: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation-associated nuclear protein Ki67. This evidence concerns the gene ERBB2 and breast cancer.